ExodusPoint Capital Management’s ARS Pharmaceuticals SPRY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$772K	Buy	+96,093	New	+$921K	0.01%	1070
2025 Q3	–	Sell	-18,217	Closed	-$318K	–	1987
2025 Q2	$318K	Sell	18,217 -179,318	-91%	-$2.59M	﹤0.01%	1235
2025 Q1	$2.48M	Buy	197,535 +172,907	+702%	+$2.08M	0.02%	624
2024 Q4	$260K	Buy	+24,628	New	+$345K	﹤0.01%	1317
2024 Q1	–	Sell	-38,022	Closed	-$208K	–	1939
2023 Q4	$208K	Buy	38,022 +26,992	+245%	+$118K	﹤0.01%	1271
2023 Q3	$42K	Buy	+11,030	New	+$72.4K	﹤0.01%	1616
2022 Q1	–	Sell	-19,148	Closed	-$128K	–	2645
2021 Q4	$128K	Buy	+19,148	New	+$156K	﹤0.01%	1915
2021 Q1	–	Sell	-20,882	Closed	-$968K	–	2572
2020 Q4	$968K	Buy	+20,882	New	+$697K	0.01%	873